Why GHRS? GH Research PLC Analysis, Price & AI Insights | Whystock
GHRS
$20.71+0.18 (+0.88%)
Market ClosedLast close May 1
GH Research PLC, together with its subsidiary, operates a clinical-stage biopharmaceutical company that develops treatments for depression in the United States.